Cargando…
An overview of the anti-SARS-CoV-2 properties of Artemisia annua, its antiviral action, protein-associated mechanisms, and repurposing for COVID-19 treatment
Artemisia annua and its phytocompounds have a rich history in the research and treatment of malaria, rheumatoid arthritis, systemic lupus erythematosus, and other diseases. Currently, the World Health Organization recommends artemisinin-based combination therapy as the first-line treatment for multi...
Autor principal: | Fuzimoto, Andréa D. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Shanghai Yueyang Hospital Affiliated to Shanghai University of Traditional Chinese Medicine. Published by ELSEVIER B.V.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8378675/ https://www.ncbi.nlm.nih.gov/pubmed/34479848 http://dx.doi.org/10.1016/j.joim.2021.07.003 |
Ejemplares similares
-
Artemisia annua L. extracts inhibit the in vitro replication of SARS-CoV-2 and two of its variants
por: Nair, M.S., et al.
Publicado: (2021) -
Artemisia annua L. extracts inhibit the in vitro replication of SARS-CoV-2 and two of its variants
por: Nair, M.S., et al.
Publicado: (2021) -
SARS-CoV-2 omicron variants succumb in vitro to Artemisia annua hot water extracts
por: Nair, M.S., et al.
Publicado: (2022) -
SARS-CoV-2 omicron variants are susceptible in vitro to Artemisia annua hot water extracts
por: Nair, M.S., et al.
Publicado: (2023) -
Emergence of terpene cyclization in Artemisia annua
por: Salmon, Melissa, et al.
Publicado: (2015)